ÑëÊÓÍø|ÖйúÍøÂçµçÊǪ́|ÍøÕ¾µØͼ |
¿Í·þÉèΪÊ×Ò³ |
ÖйúÍøÂçµçÊǪ́ > ÐÂÎĄ̊ > ÐÂÎÅÖÐÐÄ >
·¢²¼Ê±¼ä:2012Äê02ÔÂ04ÈÕ 21:12 | ½øÈ븴ÐËÂÛ̳ | À´Ô´£ºÐ»ªÍø | ÊÖ»ú¿´ÊÓƵ
΢·Ã̸ | ΢ֱ²¥ | ΢¹ã³¡ | ÃûÈËǽ | ÅÅÐаñ
• ³È×Ó´òÀ¯¸ÃÈçºÎʶ±ð • ½ÒÃؼßÊ®ÑÐÖÆÈ«¹ý³Ì
¡¡¡¡Ð»ªÍø¸ç±¾¹þ¸ù£²Ô£±Èյ磨¼ÇÕßÑî¾´ÖÒ£©×ÔÖе¤È˲źÏ×÷ÍøÈ¥Ä꣹ÔÂÆô¶¯ÒÔÀ´£¬Ô½À´Ô½¶àµÄµ¤ÂóÖªÃû´ó¹«Ë¾Í¨¹ý¸ÃÍøÂçƽ̨ÕÐļÖйúÈ˲ÅΪÆä·þÎñ£¬ÓÈÆäÊÇÓйýµ¤ÂóÇóѧºÍ¹¤×÷¾ÀúµÄ¸ß¶ËÈ˲ű¸Êܵ¤ÂóÆóÒµÇàíù¡£½üÈÕ£¬ÓÖÓÐËļÒÊÀ½çÖøÃûµÄµ¤Âó¹«Ë¾¼ÓÈë¸ÃÍøÂ磬ΪÖйúµÄ֪ʶ¾«Ó¢Ìṩ¸ü¶àµÄ¸ß¼¶Ö°Î»ºÍ´´Òµ»ú»á¡£
¡¡¡¡µ¤ÂóÍâ½»²¿ÔÚ£±ÈÕ·¢²¼µÄÐÂÎŹ«±¨ÖÐ˵£¬Ëæ×Å£²£°£±£²ÄêµÄµ½À´£¬Öе¤ÍøÂçÓÀ´ÁËËÄλÖØÁ¿¼¶µÄкÏ×÷»ï°é£¬ËüÃÇÊÇTopsoe£¨ÍÐÆÕË÷£©£¬NNE Pharmaplan£¨¶÷ÒË·©Â꣩, Novo Nordisk£¨ÅµºÍŵµÂ£©ºÍVestas£¨Î¬Ë¹Ëþ˹£©¡£ÕâËļÒÖøÃûµÄµ¤ÂóÆóÒµ¼ÓÈëÁËÖе¤ÍøÂ磬´Ó£²£°£±£²ÄêÆð×÷Ϊ¸ÃÍøÂçµÄ³ÉÔ±¼ÌÐøÍƽøÖйúѧÉúºÍÖ°Ô±Ó뵤ÂóÆóÒµ¼äµÄ½»Á÷»¥¶¯£¬²¢ÎªÖйúÓ¢²ÅÌṩǰÍùµ¤ÂóÆóÒµ¾ÍÒµºÍ·¢Õ¹µÄ»ú»á¡£
¡¡¡¡µ¤ÂóÍâ½»²¿Ëµ£¬Ä¿Ç°µ¤Âó´óѧ¼°ÆóÒµ¶ÔÖйúÈ˲ŵÄÐèÇóÓëÈÕ¾ãÔö£¬È»¶ø»ñÈ¡ÓÅÐãÈ˲Ų¢·ÇÒ×Ê¡£Öе¤ÍøÂçÒѳÉΪÖйúÈ˲ÅÓ뵤Âó¸ßУ¼°ÆóÒµ½»Á÷»¥¶¯µÄÖ÷ÒªÇþµÀ¡£µ¤·½Ï£Íûͨ¹ýÕâ¸öƽ̨ÁÔÈ¡ºÏÊÊÈ˲ţ¬Ò²ÈÃÖйúѧÉúºÍÇóÖ°ÕßÓиü¶à»ú»áÓ뵤Âó¸ßУºÍÆóÒµÖ±½Ó¹µÍ¨¡£
¡¡¡¡Öе¤ÍøÂçÓɵ¤Âó¿Æ¼¼´´ÐÂÖÐÐÄ£¨ÉϺ££©·¢Æð£¬ÁªºÏµ¤Âó¸÷¸ßУ¡¢µ¤Âóפ»ª»ú¹¹¼°²ÎÓëºÏ×÷µÄµ¤ÂóÆóÒµ¹²Í¬ÔË×÷¡£¸ÃÍøÂçÓÚ£²£°£±£±Ä꣹ÔÂÆô¶¯£¬Ö¼ÔÚΪÖйúÈ˲ÅÌṩǰÍùµ¤ÂóÁôѧÉîÔìÒÔ¼°ÔÚµ¤ÂóÆóÒµ¾ÍÒµ·¢Õ¹µÄ»ú»á¡£